Diagnosis of axillary lymph node metastases in patients with breast cancer

scientific article published on January 1996

Diagnosis of axillary lymph node metastases in patients with breast cancer is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1014521771
P356DOI10.1007/BF01806817
P698PubMed publication ID8883971

P2093author name stringM Noguchi
I Miyazaki
N Katev
P2860cites workRisk of lymphoedema following the treatment of breast cancerQ34188725
Further analysis of predictive value of Helix pomatia lectin binding to primary breast cancer for axillary and internal mammary lymph node metastasesQ35977097
Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancerQ35983140
Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significanceQ36028138
Survival and recurrences five years after selective treatment for breast carcinomaQ36042673
Helix pomatia and Ulex europeus lectin binding in human breast carcinoma.Q36446996
The axilla: not a no-go zoneQ36481740
Prognostic factors in breast-cancer and their controversies (review).Q37878948
Surgical management of stage I and stage II breast cancerQ37952746
Predictive value of lectin binding on breast-cancer recurrence and survivalQ38349289
Non-palpable lesions of the breast detected by mammography--review of 1182 consecutive histologically confirmed casesQ38511583
Modern thoughts on lymph nodes in breast cancerQ38637100
Factors affecting the incidence of lymph node metastases in small cancers of the breastQ38819432
Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor sizeQ40355725
Improved Axillary Staging of Breast Cancer with Sentinel LymphadenectomyQ40484056
Axillary dissection: current practice and techniqueQ40499790
How should the axilla be treated in breast cancer? Why I favour axillary node clearance in the management of breast cancerQ40590169
Controversies in primary breast cancer managementQ40779390
The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reactionQ41447288
Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axillaQ41779521
Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodesQ43448419
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?Q43773890
The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancerQ44101084
Clinical and biological prediction of axillary and internal mammary lymph node metastases in breast cancerQ45189104
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesQ45212226
Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumourQ45270233
Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasisQ47363180
Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancerQ50175617
Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients.Q52494641
Lack of efficacy of xeroradiography to preoperatively detect axillary lymph node metastases in breast cancer.Q52710850
The appropriate breast cancer paradigm.Q53704177
Axillary lymph node metastases in breast cancer: preoperative detection with US.Q53731414
New Therapeutic Possibilities in Primary Invasive Breast CancerQ58005119
Carcinoma in situ of the breastQ66847257
Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut CurieQ67516242
C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancerQ67516787
The Guy's trial of treatments of "early" breast cancerQ67597463
Total axillary lymphadenectomy in the management of breast cancerQ67771144
Axillary node dissection for early breast cancer: some is good, but all is betterQ68035279
Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study GroupQ68090559
Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosisQ68194992
Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancerQ68256199
Evidence for a novel gene associated with low tumor metastatic potentialQ68277146
Ultrasonographic detection of metastatic axillary lymph nodes in breast cancerQ68519748
Intraductal carcinoma of the breast. (1960-1969)Q68634226
Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 yearsQ68856475
Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patientsQ68896052
Prognosis of breast cancer with axillary node metastases after surgical treatment onlyQ69397240
The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysisQ69397249
Ultrasound detection of axillary lymph node metastases in breast cancerQ69492567
Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patientsQ69503752
Clinical evaluation of axillar lymph nodes compared to surgical and pathological findingsQ69513451
The significance of regional lymph node dissection in the surgical management of breast cancerQ69630913
Hooked-wire-directed breast biopsy and overpenetrated mammographyQ69716747
Conservative treatment of breast cancer: results of management of axillary lymph node area in 3353 patientsQ69864846
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiationQ69884400
The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trialQ69891876
MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observationsQ69945050
Patients with early breast cancer benefit from effective axillary treatmentQ70069828
CT-pathologic correlation of axillary lymph nodes in breast carcinomaQ70147057
Axillary lymph node dissection for intraductal breast carcinoma--is it indicated?Q70169494
Surgical treatment of carcinoma of the breast: II. Prognostic factors influencing relapse rateQ70186666
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateQ70280709
Manchester regional breast study--5 and 10 year resultsQ70595671
Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasisQ70611381
Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastasesQ70628565
MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlationQ70664515
Axillary nodal status in women with screen-detected breast cancerQ70710082
Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearanceQ70720534
The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breastQ70810976
Observations on short-term and long-term surveys of breast cancer by the American College of Surgeons. I. Significance of the number of axillary nodes and II. Estrogen receptor assay in the U.S. in 1977Q70828533
Nuclear magnetic resonance for the differentiation of benign and malignant breast tissues and axillary lymph nodesQ71059693
Analysis of the prognosis of minimal and occult breast cancersQ71137185
Assessment of axillary lymph node statusQ71288585
Reliability of axillary lymph node scintiphotography in suspected carcinoma of the breastQ71353210
Intraoperative assessment of axillary lymph node metastases in operable breast cancerQ71702885
Significance of Axillary Macrometastases and Micrometastases in Mammary CancerQ71757405
Lymphatic mapping and sentinel lymphadenectomy for breast cancerQ72206697
Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpabilityQ72293954
Integrin expression in primary breast cancer and its relation to axillary nodal statusQ72380672
Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearanceQ72424685
Cancer research campaign (King's/Cambridge) trial for early breast cancer. A detailed update at the tenth year. Cancer Research Campaign Working PartyQ72428294
Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reactionQ72428499
The inadequacy of axillary sampling in breast cancerQ72526584
The relationship of p53 protein and lymph node metastases in invasive breast cancerQ72700246
Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysisQ72736720
Management of the axilla in patients with breast cancers one centimeter or smallerQ72848528
Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failuresQ72939412
Controversies in the Surgical Management of Operable Breast CancerQ73223977
Significance of occult metastases.A study of breast cancerQ79053159
Nm23 expression versus helix-pomatia lectin-binding in human breast-cancer metastasesQ84089658
Immunohistochemical study of epidermal growth-factor and epidermal growth-factor receptor in breast-carcinomaQ84182421
Axillary nodes in breast cancerQ93716211
Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearanceQ93864552
P433issue3
P407language of work or nameEnglishQ1860
P1104number of pages11
P304page(s)283-293
P577publication date1996-01-01
P1433published inBreast Cancer Research and TreatmentQ326085
P1476titleDiagnosis of axillary lymph node metastases in patients with breast cancer
P478volume40

Reverse relations

cites work (P2860)
Q73192060A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society
Q37900684Axillary recurrence rate in breast cancer patients with negative sentinel lymph node biopsy or containing micrometastases and without further lymphadenectomy: a monocentric review of 8 years and 481 cases
Q34077063Axillary staging of breast cancer and the sentinel node
Q77741852Breast cancer imaging--what are the optimal modalities?
Q37542255Molecular markers of breast axillary lymph node metastasis
Q48666718New method of sentinel node detection using a combination of contrast-enhanced ultrasound and dye guidance: an animal study.
Q79978575Relationship between viral factors, axillary lymph node status and survival in breast cancer
Q34536005Sentinel lymph node biopsy and breast cancer
Q33634761Sentinel lymphadenectomy in breast cancer: identification of sentinel lymph node and detection of metastases
Q73272419Staging efficacy of breast cancer with sentinel lymphadenectomy
Q44661227The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.
Q38051233The changing role of axillary lymph node dissection for breast cancer

Search more.